Clinical trial
Maraviroc to Augment Rehabilitation Outcomes After Stroke
NCT03172026 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Maraviroc to Augment Rehabilitation Outcomes After Stroke
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- August 1, 2019
- Completion date
- October 1, 2020
- Enrollment
- 2 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.